Kura Oncology
A Business Development role at Kura Oncology focused on advancing precision cancer medicines through strategic external collaborations and corporate transactions. The position is within a clinical-stage biopharmaceutical company committed to developing small-molecule therapeutics in oncology. The role operates in a values-driven, patient-focused culture emphasizing scientific rigor and execution.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2014
Kura Oncology is a precision oncology biotechnology company focused on realizing the promise of targeted medicines to help patients with cancer lead better, longer lives. The company discovers and develops small-molecule therapies designed to inhibit specific cancer-driving pathways and genetic alterations, advancing programs through preclinical and clinical development. Kura works with clinical investigators and partners to test its candidates in genetically defined patient populations with the goal of delivering meaningful, durable treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kura Oncology.
Kura Oncology Inc. Q4 Loss Increases
1 week ago
Oncology Clinical Development Scientist
Systimmune
ProFound Therapeutics: Senior Director, Alliance Management & Business Development
Flagship Pioneering, Inc.
Scientist I, Medicinal Chemistry
Maze Therapeutics
Senior Scientist / Principal Scientist, Chemistry Lead
Relay Therapeutics
Principal Clinical Scientist - Clinical Development
Akero Therapeutics
Senior Oncology Account Manager – Detroit, MI
Revolution Medicines